Prix GALIEN

Select your category >>>

The Prix Galien internationally stands as the industry equivalent of the Nobel Prize in medical innovation.

Initially, the award originated in France, but thanks to the growing dedication of numerous companies to biomedical research and development, this esteemed prize is now granted in 15 different countries.

In Belgium, Artsenkrant/Le Journal du Médecin is the driving force behind the Prix Galien propelling innovation in the Belgian healthcare sector!

Since last year, the award has been divided into two events. The Prix Galien Medical Devices and the Prix Galien pharmaceuticals & Pharmacology.

The award for most innovative medical device went to VAX-ID® developed by IDEVAX. Intressa Vascular won the award for most promising design with their Allay®Aortic Stent.

Bristol Myers Squibb won this years Prix Galien for Pharmaceutical innovation with ‘CAMZYOS‘, a medicine used to treat adults with obstructive hypertrophic cardiomyopathy. Mandy Grootaerts was the winner of the best pharmacological research project 2023.

We hope to see you for the Prix Galien 2024!

THE PRIZE IS PRESENTED IN FOUR DISTINCT CATEGORIES:

Medical Devices

The most innovative medical device, honours a medical device that can lead to better treatment
The most promising design, dedicated to a young company showcasing an innovative product

Pharmaceuticals

The best pharmaceutical agent, reserved for the most groundbreaking pharmaceutical innovation.
The best pharmacological research project, acknowledging the contributions of a researcher or a group of researchers in the realm of clinical studies and/or fundamental research.